Advertisement
Advertisement
TOPIC

China’s private sector

China’s private sector
The latest news, analysis and opinion on China’s private sector. In-depth analysis, industry insights and expert opinion.
With an efficiency edge that transcends simple cost advantages, China is set to see the emergence of a home-grown drug giant capable of competing with global players. Photo: Shutterstock
Biomedicine: Companies

China’s drug firms set to compete on the world stage, analysts say

Amid systemic efficiency and a wave of innovation, the country’s biotech sector is expanding at a pace that has caught the market off guard.

4
Biomedicine: Industry Trends

Global pharma giants turn to Chinese biotech to tap innovation, valuation growth

Biomedicine: Companies

Sugar for the pill: US$8b fund boosts Hong Kong’s biotech hub ambitions

China stock market

Global AI trade revival brightens outlook for Chinese tech stocks

Improved corporate earnings and a broader global tech rebound are helping stocks bounce back from a record monthly decline.

The tech-heavy Star Market 50 Index on the Shanghai Stock Exchange is expected to close the week up by about 6 per cent. Photo: Shutterstock
Banking & finance

China’s foreign reserves hold steady as external earnings stay in private hands

Hong Kong absorbed nearly two-thirds of mainland China’s portfolio outflows last year and now holds about half of the total external stock, IIF says.

China stock market

Not like South Korea? Chinese brokers forecast A-share tech and chip rebound

As global investors pull money from South Korea, top domestic brokerages expect strong domestic fundamentals to drive fresh buying in China.

Advertisement
Advertisement
Advertisement
Artificial intelligence

Chasing physical AI: Ant Group robotics arm Robbyant kicks off external funding

The division seeks US$222 million in the first round and could complete a second by year-end, according to domestic media reports.

Robbyant, an embodied intelligence company under Ant Group, showcases its R1 robot, which is capable of cooking complete meals with minimal human intervention, at the technology exhibition during the 2025 Inclusion Conference in Shanghai on September 12, 2025. Photo: VCG via Getty Images
Artificial intelligence

China’s tech giants race to put AI on delivery riders’ heads

From safety features to hands-free voice tools, JD.com has become the latest platform to launch AI-integrated headwear.

Millionaires, billionaires and trillionaires

Why 17 people have held title of China’s richest person in past 27 years

ByteDance founder Zhang Yiming tops rankings this year, but vibrant market makes them much more fluid than in US, Hurun says.

IPO

AI stock rout fells Innolight after mega Hong Kong IPO

Nvidia supplier Innolight declines on its Hong Kong trading debut as once AI-hungry investors turn increasingly nervous about sector’s huge spending plans.

The listing ceremony for Zhongji Innolight. Photo: Jonathan Wong
China technology

Why has the China-US profit gap widened on the Fortune Global 500?

Despite posting strong revenues, China’s multinationals logged average profits of US$4.5 billion in 2025, just 40 per cent of US counterparts’ figure.

videocam
33
China’s multinationals are falling behind their US peers in profits, despite recording strong revenue. Photo: SOPA Images/LightRocket via Getty Images
Hong Kong stock market

Why is Zhongji unveiling US$1.2 billion in buy-backs before its Hong Kong debut?

The optical-module maker plans to buy back shares denominated in yuan to anchor pricing before its initial public offering in the city.

Hong Kong

China’s ATRenew has big plans for Hong Kong’s little-known phone trading hub

New York-listed firm aims to modernise the city’s opaque wholesale market, which sits at the centre of a vast global network for used devices.

China consumption

China’s Pop Mart opens new store in Singapore’s Sentosa as domestic sales slow

Popular toymaker targets global expansion and revenue diversification, looking beyond just collectibles.

Pop Mart has opened a new store in Sentosa, Singapore. Photo: Handout
China's economic recovery

Payment arrears and ‘involution’ still slam traditional China industries: survey

Most entrepreneurs polled cite problematic payment delays and intense competition, even as AI, semiconductors and advanced materials lift profits.

15
A worker checks automated spool winders at a factory in China’s Zhejiang province last month. A recent poll of private firms in the country found that many are still struggling. Photo: Xinhua
China GDP

China’s ‘K-shaped’ economy is divided not just by sector, but geography

The divide between China’s booming tech industry and struggling consumer sector has drawn attention. But regional disparities are also widening.

videocam
China consumption

Meet Yu Donglai, founder of China’s viral supermarket chain and premier’s guest

Yu’s company has caught the public’s attention for its business practices and high-quality goods.

Advertisement
Advertisement
Advertisement
Mainland China

China hits Trip.com with US$765 million antitrust penalty

The country’s biggest online travel services provider is accused of abusing its ‘dominant market position’.

Trip.com reported revenue of 62.4 billion yuan in 2025, up 17 per cent year on year. Photo: Shutterstock
Investing

How Beijing became China’s biggest tech venture capitalist, from AI to chips

China’s tech sector thrives on state-backed investment, reshaping funding dynamics and sparking a debate about balancing risk and innovation.

5
China energy security

Power play: CATL wades into hydropower as China opens state projects further

Battery giant’s stake in Sichuan plant reflects Beijing’s push to diversify funding and inject market discipline into public infrastructure.

Mainland China

China’s tycoons rein in charitable donations, switch focus to science, education

One major driver of overall decline in corporate donations has been the prolonged slump in country’s real estate sector.

ByteDance founder Zhang Yiming has donated 1.1 billion yuan to projects in his hometown over the past five years. Photo: AFP
China tariffs

What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?

Analysts say that China’s pivot from generics to innovative drugs means the industry is less exposed to US levies.

videocam
16
A production line of capsule package. Photo: Getty Images
Biomedicine: Industry Trends

‘Historic breakthrough’: China approves novel drug ahead of US, Japan and Europe

Push to accelerate novel drug reviews promises earlier access to breakthrough therapies for patients long left waiting.

Hong Kong

Fifa effect: Hong Kong developers bet on sport fever to keep shoppers spending

Neighbourhood malls to host year-round events encouraging consumers to open their wallets after World Cup mania delivers double-digit gains.

videocam
Biomedicine: Companies

‘Systemic leap’: China’s drug innovation push yields bumper crop

Home-grown therapies account for 80 per cent of approvals in first six months of the year.

videocam
In addition to surging novel drug development, China’s cross-border deals with global giants show no sign of abating. Photo: Shutterstock
Ctrip

China to conclude Trip.com antitrust probes as soon as this week, sources say

Market regulator expected to close investigation into top online travel service provider, with potential fines running into billions of yuan.

Trip.com is expected to face fines of up to 6 billion yuan. Photo: Shutterstock
Artificial intelligence

To survive China’s cost-conscious market, global brands embrace AI and robots

From L’Oréal to Coca-Cola, major multinationals are embedding cutting-edge technologies into operations to compete with local rivals.

Banking & finance

Mainland funds boost stakes in Hong Kong-listed biotech amid value dislocation

Analysts say valuation of the sector is attractive, with biotech firms trading relatively cheaply.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement